AstraZeneca Revamps NYSE Listing To Woo US Investors

By Najiyya Budaly ( September 29, 2025, 11:16 AM BST) -- Pharmaceutical heavyweight AstraZeneca PLC said on Monday that it is overhauling its New York listing in an effort to attract U.S. investors but will retain its primary listing and headquarters in the U.K....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login